Liposomal irinotecan together with vincristine and temozolomide (NALIRI-VT) for patients with relapsed or refractory Ewing sarcoma: A two-cohort, phase 1a/1b study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results